EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies

Mem Rani, Nansiben Patel, Mounika Duppala, Alyssa Ragusa, Megha Darji, Kishore Kumar Hotha

American Journal of Analytical Chemistry · 2026 · 17 (06) · 212-234

DOI: 10.4236/ajac.2026.176013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Analytical Chemistry, 2026. Verfasst von Mem Rani und 5 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rani, M., Patel, N., Duppala, M., Ragusa, A., Darji, M., & Hotha, K. K. (2026). Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies. American Journal of Analytical Chemistry, 17(06), 212-234. https://doi.org/10.4236/ajac.2026.176013

Vancouver

Rani M, Patel N, Duppala M, Ragusa A, Darji M, Hotha KK. Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies. American Journal of Analytical Chemistry. 2026;17(06):212-234. doi:10.4236/ajac.2026.176013

BibTeX
@article{Rani2026,
  author = {Rani, Mem and Patel, Nansiben and Duppala, Mounika and Ragusa, Alyssa and Darji, Megha and Hotha, Kishore Kumar},
  title = {Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies},
  journal = {American Journal of Analytical Chemistry},
  year = {2026},
  volume = {17},
  number = {06},
  pages = {212--234},
  doi = {10.4236/ajac.2026.176013}
}
Kostenlos starten →